Live Breaking News & Updates on National expert group on vaccine administration

Stay updated with breaking news from National expert group on vaccine administration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Expert groups considering scientific evidence on justification for Covid vaccine booster dose: Govt

New Delhi, December 10 (PTI): The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and the National Technical Advisory Group on Immunisation (NTAGI) are considering scientific evidences related to justification for booster doses again

India , Vellore , Tamil-nadu , New-delhi , Delhi , Bharat , Har-ghar-dastak , Lok-sabha , Christian-medical-college , National-expert-group-on-vaccine-administration , Serum-institute , Health-bharati-pravin-pawar

India News | Health Ministry Along with NTAGI, NEGVAC, Should Assess Need for Covid-19 Booster Doses, Recommends House Panel

Get latest articles and stories on India at LatestLY. In view of the threat posed by the new Omicron variant of COVID-19, the Parliamentary Standing Committee on Home Affairs has recommended that the Health Ministry in coordination with the National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) should assess the need for booster doses in India. India News | Health Ministry Along with NTAGI, NEGVAC, Should Assess Need for Covid-19 Booster Doses, Recommends House Panel.

Jammu , Jammu-and-kashmir , India , New-delhi , Delhi , Anand-sharma , Ministry-of-health-family-welfare-mo , Parliamentary-standing-committee-on-home-affairs , Health-system-preparedness-package , National-expert-group-on-vaccine-administration , Ministry-of-health-family-welfare , Health-ministry

CDSCO panel seeks clinical trial data from Serum for approval of Covishield as booster dose

Recently, states like Kerala, Rajasthan, Karnataka and Chhattisgarh urged the Centre to decide on allowing booster doses of COVID-19 vaccine amid concerns raised by 'Omicron'.

Karnataka , India , Delhi , Chhattisgarh , United-kingdom , Kerala , Pune , Maharashtra , Astrazeneca-chadox , Prakash-kumar-singh , National-expert-group-on-vaccine-administration , Serum-institute

India News | Covid: Dr Reddy's Laboratories Seeks DCGI's Nod for Phase-3 Trial of Sputnik Light as Booster Dose

India News | Covid: Dr Reddy's Laboratories Seeks DCGI's Nod for Phase-3 Trial of Sputnik Light as Booster Dose
latestly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from latestly.com Daily Mail and Mail on Sunday newspapers.

India , Telangana , Andhra-pradesh , United-kingdom , New-delhi , Delhi , Astrazeneca-chadox , Prakash-kumar-singh , Lok-sabha , Mansukh-mandaviya , Union-health , Regulatory-affairs-at-dr-reddy-laboratories

NTAGI meeting: No final recommendation on additional dose, COVID vaccine for children, say sources

In the National Technical Advisory Group on Immunization (NTAGI) on Monday, no final recommendation was made on additional COVID-19 vaccine dose and vaccine for children.

India , New-delhi , Delhi , Lok-sabha , Mansukh-mandaviya , Union-health , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunization , National-technical-advisory-group , Union-health-minister-mansukh-mandaviya , National-expert-group , Vaccine-administration

No final recommendation on additional COVID vaccine dose, vaccine for children in NTAGI meeting: Official sources

After a long meeting of the National Technical Advisory Group on Immunization (NTAGI) on Monday, no final recommendation was made on additional COVID-19 vaccine dose and vaccine for children, informed the official sources.

India , Lok-sabha , Mansukh-mandaviya , Union-health , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunization , National-technical-advisory-group , Union-health-minister-mansukh-mandaviya , National-expert-group , Vaccine-administration , No , Inal

No Consensus On Additional Doses, Jabs For Children At Top Panel Meet

At a long meeting on Monday held amid the rise of Omicron cases, the government's top vaccine advisory panel failed to arrive at a consensus on a booster dose or vaccination of children.

India , Mansukh-mandaviya , National-expert-group-on-vaccine-administration , Genomics-consortium , Children-at-top-panel-meet , Adar-poonawala-serum-institute-of-india , National-technical-advisory-group-on-immunization , National-technical-advisory-group , Minister-mansukh-mandaviya , National-expert-group , Vaccine-administration , Serum-institute

COVID vaccine booster shots important for frontline workers amid Omicron threat: IMA Chief

Booster doses are important to enhance the immunity of our healthcare workers amid Omicron threat, said Dr Jayalal

India , New-delhi , Delhi , Narendra-modi , Lok-sabha , National-technical-group-on-immunisation , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunization , Indian-medical-associated , Prime-minister-narendra-modi , National-technical-group , National-technical-advisory-group

Amid Omicron fears, NTAGI panel to decide on COVID-19 booster dose, vaccine for children

Amid Omicron fears, NTAGI panel to decide on COVID-19 booster dose, vaccine for children - A government panel will be meeting today to discuss child immunization in the country and the need for a COVID-19 booster dose.

India , Lok-sabha , Mansukh-mandaviya , Union-health , National-technical-group-on-immunisation , National-expert-group-on-vaccine-administration , National-technical-group , Union-health-minister-mansukh-mandaviya , National-expert-group , Vaccine-administration , Omicron-variant , Micron-fear

Govt panel to discuss child immunisation, decide on COVID-19 booster dose amid Omicron fears

During today’s meeting, the NTAGI will be coming up with comprehensive policies for both the additional COVID-19 vaccine dose and child immunisation against COVID-19. This decision comes in view of the new Omicron variant of COVID-19 of which India has reported 21 cases so far.

India , New-delhi , Delhi , Lok-sabha , Mansukh-mandaviya , Union-health , National-technical-group-on-immunisation , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunization , National-technical-group , Union-health-minister-mansukh-mandaviya , National-technical-advisory-group